title: New guidelines: it's complicated.
authors: Dr. Sawaya is from the Department of Obstetrics, Gynecology and Reproductive Sciences and the Department of Epidemiology & Biostatistics at the University of California San Francisco, San Francisco, California; e-mail: sawayag@obgyn.ucsf.edu.
authors: George F
authors: GF
authors: Sawaya
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology*; D002278:Carcinoma in Situ / Q000473:pathology*; D055088:Early Detection of Cancer / Q000592:standards*; D005260:Female; D006801:Humans; D002583:Uterine Cervical Neoplasms / Q000473:pathology*; D002578:Uterine Cervical Dysplasia / Q000473:pathology*
references: Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, et al.. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol 2013;121:829–46.
references: Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al.. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 2012;137:516–42.
references: Screening for cervical cancer. Practice Bulletin No. 131. American College of Obstetricians and Gynecologists. Obstet Gynecol 2012;120:1222–38.
references: Kuppermann M, Melnikow J, Slee C, Tancredi DJ, Kulasingam S, Birch S, et al.. Preferences for surveillance strategies for women treated for high-grade precancerous cervical lesions. Gynecol Oncol 2010;118:108–15.